José María
López-Picazo González
Consultor Médico
Ignacio
Gil Bazo
Investigador hasta 2022
Publicaciones en las que colabora con Ignacio Gil Bazo (18)
2022
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
2020
-
Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients
Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348
-
Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade
Nature cancer, Vol. 1, Núm. 1, pp. 75-85
2019
-
Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies
TH Open
-
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809
-
The dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patients
Disease Markers, Vol. 2019
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
PLoS ONE, Vol. 13, Núm. 8
-
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
Lung Cancer, Vol. 122, pp. 120-123
2017
-
Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancer
Hospital practice (1995), Vol. 45, Núm. 3, pp. 70-75
-
The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche
Cancer Letters, Vol. 402, pp. 43-51
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694
2015
-
Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study
Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148
2013
-
Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy
Journal of Translational Medicine, Vol. 11, Núm. 1
2012
-
The multimodal management of locally advanced N2 non-small cell lung cancer: Is there a role for surgical resection? A single institution's experience
Clinical and Translational Oncology, Vol. 14, Núm. 11, pp. 835-841
2009
-
Adult onset Still's disease after first cycle of pemetrexed and gemcitabine for non-small cell lung cancer
Lung Cancer, Vol. 64, Núm. 1, pp. 124-126
-
Fibrosing cholestatic hepatitis following cytotoxic chemotherapy for small-cell lung cancer
World Journal of Gastroenterology, Vol. 15, Núm. 18, pp. 2290-2292
-
Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin b12 and folic acid supplementation for advanced non-small cell lung cancer
Onkologie, Vol. 32, Núm. 10, pp. 580-584